Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CNIH2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | RUFY3 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | SF3B4 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | ZNF790 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | KCNH8 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ZNF146 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | RASGEF1B | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | SYT1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | CCNE2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | KIF5C | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |